1. Suppression of the fibrotic encapsulation of silicone implants by inhibiting the mechanical activation of pro-fibrotic TGF-β
- Author
-
Maya Ezzo, Nuno M. Coelho, Stellar Boo, Sander van Putten, David W. Griggs, Boris Hinz, Christopher A. McCulloch, Nina Noskovičová, Ronen Schuster, Peter G. Ruminski, and Anne Koehler
- Subjects
0301 basic medicine ,Silicones ,Biomedical Engineering ,Medicine (miscellaneous) ,Bioengineering ,Focal adhesion ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Silicone ,Transforming Growth Factor beta ,Animals ,Myofibroblasts ,biology ,Foreign-Body Reaction ,technology, industry, and agriculture ,Prostheses and Implants ,Transforming growth factor beta ,Fibroblasts ,equipment and supplies ,Fibrosis ,In vitro ,Computer Science Applications ,Cell biology ,030104 developmental biology ,chemistry ,biology.protein ,Implant ,Myofibroblast ,030217 neurology & neurosurgery ,Intracellular ,Biotechnology ,Transforming growth factor - Abstract
The fibrotic encapsulation of implants involves the mechanical activation of myofibroblasts and of pro-fibrotic transforming growth factor beta 1 (TGF-β1). Here, we show that both softening of the implant surfaces and inhibition of the activation of TGF-β1 reduce the fibrotic encapsulation of subcutaneous silicone implants in mice. Conventionally stiff silicones (elastic modulus, ~2 MPa) coated with a soft silicone layer (elastic modulus, ~2 kPa) reduced collagen deposition as well as myofibroblast activation without affecting the numbers of macrophages and their polarization states. Instead, fibroblasts around stiff implants exhibited enhanced intracellular stress, increased the recruitment of αv and β1 integrins, and activated TGF-β1 signalling. In vitro, the recruitment of αv integrin to focal adhesions and the activation of β1 integrin and of TGF-β were higher in myofibroblasts grown on latency-associated peptide (LAP)-coated stiff silicones than on soft silicones. Antagonizing αv integrin binding to LAP through the small-molecule inhibitor CWHM-12 suppressed active TGF-β signalling, myofibroblast activation and the fibrotic encapsulation of stiff subcutaneous implants in mice. The fibrotic encapsulation of subcutaneous silicone implants in mice can be suppressed by softening the implant surface or inhibiting the integrin-mediated activation of transforming growth factor beta 1.
- Published
- 2021
- Full Text
- View/download PDF